President Donald Trump's pledge to lower prices at the pump is getting tested by US and ... has committed to sweeping away regulation of the oil and gas industry, that might not be enough ...

President Trump’s tariff on Canadian oil is expected to raise prices at the pump for U.S. consumers, if it takes effect as planned after a 30-day delay. Analysts told The Hill that the 10 ...

The real-time price of Brent crude oil is at $74.51 per barrel, and the price of WTI crude oil is at $70.76 per barrel. Oil prices are customarily quoted in dollars (USD) around the world, not only in ...

There’s a reason 700K+ energy professionals have subscribed.

NEW YORK (Reuters) -U.S. consumers will see higher prices at the gas pump from President Donald Trump's decision on Saturday to apply tariffs on Canadian and Mexican oil, according to analysts and ...

1 Barrel = 42 Gallons Oil (WTI) Price Per 1 Gallon 1.69 USD 1 Barrel ≈ 0,136 Tonnes of Crude Oil Oil (WTI) Price Per 1 Ton 522.57 USD 1 Barrel ≈ 158,98 Liters Oil (WTI) Price Per 1 Liter 0.45 ...

2-Year U.S. Treasury Note Continuous Contract $102.691-0.172-0.17% 5-Year U.S. Treasury Note Continuous Contract $106.391-0.344-0.32% 10-Year U.S. Treasury Note Continuous Contract $109.156-0.422 ...

Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Oil has made headlines during this coronavirus crisis, although not for reasons investors want to see. In addition to issues caused by international events, especially those that impede the safe ...

© 2016 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. Information ...

The popularity of a new generation of weight-loss medicines is inspiring a growing number of drugmakers to pursue paths emulating Eli Lilly's highly-effective Zepbound, but Amgen is taking a ...